Literature DB >> 20545483

Constant voltage 'Iron'tophoresis.

Siva Ram Kiran Vaka1, H N Shivakumar, S Narasimha Murthy.   

Abstract

The objective of this study was to investigate the feasibility of rapid administration of iron via transdermal route as an alternative to parenteral route of administration. In vitro drug delivery studies were carried out using porcine epidermis mounted on Franz diffusion cells. The effect of chemical permeation enhancers and physical techniques (constant voltage iontophoresis, electroporation and combination of electroporation with iontophoresis) on the transport of ferric pyrophosphate (FPP) was studied. Transepidermal water loss (TEWL) and electrical resistance were measured in order to see the effect of these techniques on the skin barrier function. The amount of FPP permeated was not enhanced significantly with the use of any of the enhancers (P > 0.05). It was found that constant voltage iontophoresis (0.5, 2 or 4 V) for about 30 min across electroporated epidermis (120 V, 100 pulses, 10 ms at 5 Hz) enhanced the delivery of FPP over control in the range of 2- to 42-fold. Hence, a therapeutically required dose of iron could be delivered by transdermal route using electrically-mediated techniques.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20545483      PMCID: PMC5728165          DOI: 10.3109/10837450.2010.492219

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  17 in total

Review 1.  Skin electroporation for transdermal and topical delivery.

Authors:  Anne-Rose Denet; Rita Vanbever; Véronique Préat
Journal:  Adv Drug Deliv Rev       Date:  2004-03-27       Impact factor: 15.470

2.  Local and transient structural changes in stratum corneum at high electric fields: contribution of Joule heating.

Authors:  U Pliquett; S Gallo; S W Hui; Ch Gusbeth; E Neumann
Journal:  Bioelectrochemistry       Date:  2005-09       Impact factor: 5.373

3.  Body iron and individual iron prophylaxis in pregnancy--should the iron dose be adjusted according to serum ferritin?

Authors:  Nils Milman; Keld-Erik Byg; Thomas Bergholt; Lisbeth Eriksen; Anne-Mette Hvas
Journal:  Ann Hematol       Date:  2006-05-30       Impact factor: 3.673

Review 4.  Iron monitoring and supplementation: how do we achieve the best results?

Authors:  R M Schaefer; L Schaefer
Journal:  Nephrol Dial Transplant       Date:  1998       Impact factor: 5.992

Review 5.  Iron deficiency anemia.

Authors:  Shersten Killip; John M Bennett; Mara D Chambers
Journal:  Am Fam Physician       Date:  2007-03-01       Impact factor: 3.292

6.  Low compliance with an iron-supplementation program: a study among pregnant women in Jakarta, Indonesia.

Authors:  W Schultink; M van der Ree; P Matulessi; R Gross
Journal:  Am J Clin Nutr       Date:  1993-02       Impact factor: 7.045

7.  The rationale for treating iron deficiency anemia.

Authors:  W H Crosby
Journal:  Arch Intern Med       Date:  1984-03

Review 8.  Diagnosis and management of iron-deficiency anaemia.

Authors:  James D Cook
Journal:  Best Pract Res Clin Haematol       Date:  2005-06       Impact factor: 3.020

9.  Iron exchange between transferrin molecules mediated by phosphate compounds and other cell metabolites.

Authors:  E H Morgan
Journal:  Biochim Biophys Acta       Date:  1977-08-25

10.  'Oversaturation' of transferrin after intravenous ferric gluconate (Ferrlecit(R)) in haemodialysis patients.

Authors:  A L Zanen; H J Adriaansen; E F van Bommel; R Posthuma; G M Th de Jong
Journal:  Nephrol Dial Transplant       Date:  1996-05       Impact factor: 5.992

View more
  2 in total

1.  Transdermal Delivery of Iron Using Soluble Microneedles: Dermal Kinetics and Safety.

Authors:  Naresh Modepalli; H Nanjappa Shivakumar; Maeliosa T C McCrudden; Ryan F Donnelly; Ajay Banga; S Narasimha Murthy
Journal:  J Pharm Sci       Date:  2016-03       Impact factor: 3.534

2.  Microporation and 'iron'tophoresis for treating iron deficiency anemia.

Authors:  Naresh Modepalli; Seongbong Jo; Michael A Repka; S Narasimha Murthy
Journal:  Pharm Res       Date:  2012-11-28       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.